Kerber Richard E
University of Iowa Hospitals, 200 Hawkins Drive, Iowa City, IA 52242, USA.
Trans Am Clin Climatol Assoc. 2011;122:59-69.
Reducing body temperature to 33 °C in patients who have been resuscitated from cardiac arrest but who remain comatose can ameliorate anoxic encephalopathy and improve recovery. Experimental animal studies have suggested that cooling to 33 °C also aids the resuscitative process itself, facilitating the resumption of spontaneous circulation (ROSC). The mechanism of cooling benefit is probably the reduction of metabolic demand of most organs, and reduced production of toxic metabolites and reactive oxygen species. External cooling by application of ice or pads through which cold water circulates is effective but requires up to 8 hours to achieve the target temperature of 33 °C. Our goal was to develop a faster method of cooling that could be initiated during cardiopulmonary resuscitation. In anesthetized swine, we induced ventricular fibrillation by passing alternating current down an electrode catheter in the right ventricle. We then ventilated the animals' lungs with liquid perfluorocarbons (PFCs), a technique known as total liquid ventilation (TLV). Perfluorocarbons are oxygen-carrying modules; we pre-oxygenated the PFCs by bubbling 100% O(2) through the solution for 2 minutes before use, and pre-cooled the PFCs to -15 °C. The cold oxygenated PFCs reduced pulmonary artery temperature (a surrogate for myocardial temperature) to 33 °C in about 6 minutes. Using this technique we achieved ROSC in 8 of 11 (82%) animals given TLV versus 3 of 11 (27%) control animals receiving conventional CPR without PFCs (P<0.05). We also compared the cold TLV technique with the administration of intravenous iced saline to achieve hypothermia. Both the cold TLV and cold saline techniques produced rapid hypothermia, but we could achieve ROSC in only 2 of 8 (25%) animals given cold saline versus 7 of 8 (88%) given cold TLV. This result is likely due to the rise in right atrial pressure and corresponding reduction in coronary perfusion pressure caused by volume loading with IV saline, in addition to the higher pO(2) associated with pre-oxygenated PFCs. Cold TLV is a promising technique for achieving rapid intra-arrest and post-resuscitation hypothermia in patients experiencing cardiac arrest.
对于心脏骤停复苏后仍昏迷的患者,将体温降至33°C可改善缺氧性脑病并促进恢复。实验动物研究表明,冷却至33°C也有助于复苏过程本身,促进自主循环恢复(ROSC)。降温有益的机制可能是大多数器官代谢需求的降低,以及有毒代谢产物和活性氧生成的减少。通过应用冰袋或循环冷水的垫子进行外部降温是有效的,但需要长达8小时才能达到33°C的目标温度。我们的目标是开发一种更快的降温方法,可在心肺复苏期间启动。在麻醉的猪中,我们通过将交流电通过右心室的电极导管来诱发心室颤动。然后我们用液态全氟碳化合物(PFCs)对动物的肺部进行通气,这一技术称为全液体通气(TLV)。全氟碳化合物是携氧模块;我们在使用前通过将100% O₂ 鼓泡通过溶液2分钟对PFCs进行预充氧,并将PFCs预冷至-15°C。冷的充氧PFCs在约6分钟内将肺动脉温度(心肌温度的替代指标)降至33°C。使用该技术,接受TLV的11只动物中有8只(82%)实现了ROSC,而接受无PFCs的传统心肺复苏的11只对照动物中有3只(27%)实现了ROSC(P<0.05)。我们还将冷TLV技术与静脉输注冰盐水以实现低温进行了比较。冷TLV和冷盐水技术均能快速降低体温,但接受冷盐水的8只动物中只有2只(25%)实现了ROSC,而接受冷TLV的8只动物中有7只(88%)实现了ROSC。这一结果可能是由于静脉输注盐水导致容量负荷引起右心房压力升高和冠状动脉灌注压力相应降低,此外还与预充氧PFCs相关的较高pO₂ 有关。冷TLV是一种在心脏骤停患者中实现快速心脏骤停期间和复苏后低温的有前景的技术。